Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Mitsubishi Tanabe Pharma America announced Oxford BioDynamics has joined the REFINE-ALS study, which was designed to identify and measure specific biomarkers in people with ALS.
read more
Oxford Biomedica plc announced that it has completed the acquisition of ABL Europe SAS from Institut Mérieux SA.
read more
Oxford Biomedica announced the UK MHRA has issued a Certificate of GMP compliance for the fourth GMP manufacturing suite within the Group’s new Oxbox manufacturing facility.
read more
Thursday, January 21, 2021
Oxford BioTherapeutics has selected a second bispecific program that will combine an anti-PD-L1 antibody with OBT’s immuno-oncology candidate.
read more
Wednesday, October 26, 2016
Oxford Genetics Ltd, a biotech company which specializes in DNA design, protein expression optimization and cell line development technologies and services, has moved its operations to new state-of-the-art laboratories at The Oxford Science Park.
read more
Wednesday, September 13, 2017
Oxford Genetics has opened its first U.S. office located at the NGIN workplace near Kendall Square in the Cambridge district of Boston.
read more
Tuesday, December 20, 2016
Oxford Genetics Ltd, a biotech company that which specializes in DNA design, protein and viral expression systems, and cell line engineering, has secured a £1.61 million grant from Innovate UK. The funding will support a new research project ...
read more
Oxford Genetics announced a £7.5 million investment into its operations in the US and the UK by Mercia Technologies PLC, an existing investor, and Invesco Perpetual.
read more
Wednesday, August 08, 2018
Oxford Genetics has secured a contract with a leading multi-billion dollar global ecommerce provider of reagents and tools to the research and clinical community.
read more
Thursday, September 19, 2019
Caribou has granted Oxford Nanopore a worldwide, non-exclusive license under foundational CRISPR-Cas9 intellectual property controlled by Caribou for nanopore sequencing.
read more
Wednesday, January 13, 2021
OXGENE™ has announced the introduction of its self-labelling integral membrane (SLIM™) protein discovery system.
read more
Tuesday, September 29, 2020
OXGENE™ has announced the launch of its scalable, plasmid-free manufacturing system for AAV.
read more
Wednesday, December 06, 2023
Oz-UK Ltd, a contract research organization (CRO) specializing in pressurized metered dose inhaler (pMDI) and liquid aerosol research and development (R&D), has announced the installation of a new manufacturing line with low global warming potential ...
read more
Monday, September 11, 2017
OZMOSI announced the launch of a new global website which consolidates clinical trial data from all around the world into a single searchable database, GlobalClinicalTrialsData.com.
read more
Pace Analytical announces the acquisition of REIC Laboratories, a full-service environmental testing laboratory with multiple locations throughout Virginia and West Virginia.
read more